M&A After losing out on two big deals, Sanofi to buy Bioverativ ... French pharma makes move into haemophilia market.
News Sanofi to pay back Philippines after Dengue vaccine problems Sanofi’s is to pay back money to the Philippines government for unused doses of its Dengue fever vaccine, after serious safety concerns halted its use.
News Lilly to research real world diabetes with digital health fi... Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.
News Sanofi's Dengue vaccine launch turns into nightmare Philippines halts vaccination programme on safety issues
US Sanofi turns the tables on Lilly with biosimilar fast-acting... Big-selling Humalog facing cut price competition
News Dance Biopharm to develop inhaled insulin with Phillips-Medi... Biotech working on soft mist insulin delivery device with IT firm
News Beacon's XLRP gene therapy set for filing after phase 3 win Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
